Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
You Lü, Jianxin Xue, Tao Deng, Xiaojuan Zhou, Kun Yu, Lei Deng, Meijuan Huang, Xin Yi, Maozhi Liang, Yu Wang, Haige Shen, Ruizhan Tong, Wenbo Wang, Li Li, Jin Sook Song, Jing Li, Xiaoxing Su, Zhenyu Ding, Youling Gong, Jiang Zhu, Yongsheng Wang, Bingwen Zou, Yan Zhang, Yanying Li, Lin Zhou, and 13 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1038/s41591-020-0840-5
- Published
- Apr 27, 2020
- Venue
- Nature Medicine
- DOI
- 10.1038/s41591-020-0840-5
- PubMed
- 32341578
- Categories
- CAR-T cell therapy research
- Provenance
- openalex